← Leaderboards
Eugene E. Wolfel
University Of Colorado Denver
$566,369
Attributed
$566,369
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$566,369 · 1
By mechanism
U01$566,369 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Michael R. Bristow$7,111,960
- Paula Riggs$36,042,072
- Bryan R Haugen$9,253,787
- Spero M Manson$45,709,705
- Brian D Lowes$1,893,454
Others in their field
Top investigators on “Beta Antiadrenergic Agent”
- Christopher M O'Connor · Duke University$18,508,673
- Michael A Kass · Washington University$9,081,282
- Bruce M Psaty · University Of Washington$5,047,845
- Kenneth Allen Holroyd · Ohio University Athens$2,665,090
- Jeffrey H Silverstein · Mount Sinai School Of Medicine Of Nyu$2,655,974
- Susan Heckbert · University Of Washington$2,562,214
Research focus
Beta Antiadrenergic AgentCardiovascular Disorder ChemotherapyCardiovascular Disorder EpidemiologyCardiovascular Disorder TherapyClinical ResearchClinical TrialsCombination TherapyCongestive Heart FailureCooperative StudyCost EffectivenessDigoxinExerciseHospital UtilizationHuman MortalityHuman SubjectHuman Therapy EvaluationLongitudinal Human StudyMedical ComplicationOutcomes ResearchPatient Oriented ResearchAce InhibitorsQuality Of Life
Grant awards (4)
ACTION - A CHF Trial Investigating Outcomes of Exercise$25,000
U01 · FY2005 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$79,247
U01 · FY2004 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$293,222
U01 · FY2003 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$168,900
U01 · FY2002 · HL